Company page

Bridgebio Oncology Therapeutics, Inc.

Bridgebio Oncology Therapeutics, Inc. is a public company listed under the ticker BBOT, operating in the American market. The company focuses on developing innovative therapies for cancer treatment. As of now, Bridgebio has a market capitalization of approximately $666.5 million.